ÂÜÀòÂÒÂ×

Ethel Koczon joined Chiasma in May 2015 as our Sr. Director, Clinical Operations. After over three years of service dedicated to our Phase 3 clinical trial program, she was promoted to Vice President of that same department. Prior to joining Chiasma, she held similar positions at MEI Pharma, Intelikine (acquired by Takeda/Millenium in 2012), Salmedix (acquired by Cephalon in 2005), Ionis Pharmaceuticals (formerly Isis), and the CRO, IBRD/Rostrum. Ethel’s extensive background includes the role of Partner and Chief Operating Officer of Exact Clinical Research Services, a niche CRO serving start-up biotechs. She began her career in Development as a Research Scientist at Johnson & Johnson. In addition, Ethel taught Clinical Trial Design and Management courses for the USCD Extension Program. Ethel holds a B.A. in Biology from the University of California, San Diego and Medical Technologist, ASCP from Scripps, CA.